|
Escitalopram Clinical Trials
11 actively recruiting trials across 2 locations
Also known as: ATC code: N06AB10, Active Comparator, Cipralex, Lexapro
Pipeline
Phase 2: 2Phase 3: 2Phase 4: 5
Top Sponsors
- University of Cincinnati3
- Dr. Inge Winter2
- Vigonvita Life Sciences1
- University of Texas Southwestern Medical Center1
- Poznan University of Medical Sciences1
Indications
- Depression9
- Anxiety3
- Bipolar Depression2
- Major Depressive Disorder2
- Anxious Depression1
Other7 trials
Cincinnati, Ohio3 trials
Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)
University of Cincinnati
Phase 4
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience
Phase 4
Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)
University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience
Phase 4
Dallas, Texas1 trial
Escitalopram in Asthma Patients With Frequent Exacerbation
UT Southwestern, 1440 Empire Central, Ste. LD4.100
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.